John B. Bode - 18 May 2023 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Role
Director
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for John B. Bode
Issuer symbol
ZVRA
Transactions as of
18 May 2023
Net transactions value
+$50,418
Form type
4
Filing time
19 May 2023, 17:53:37 UTC
Previous filing
08 May 2023
Next filing
06 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZVRA Common Stock Purchase $6,999 +1,390 $5.04 1,390 18 May 2023 Direct
transaction ZVRA Common Stock Purchase $1,512 +300 +22% $5.04 1,690 18 May 2023 Direct
transaction ZVRA Common Stock Purchase $5,040 +1,000 +59% $5.04 2,690 18 May 2023 Direct
transaction ZVRA Common Stock Purchase $23,985 +4,759 +177% $5.04 7,449 18 May 2023 Direct
transaction ZVRA Common Stock Purchase $504 +100 +1.3% $5.04 7,549 18 May 2023 Direct
transaction ZVRA Common Stock Purchase $12,378 +2,451 +32% $5.05 10,000 18 May 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.